Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion
Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion zbecker Thu, 02/29/2024 - 15:09
Sarepta details Elevidys launch progress while awaiting key FDA decision on label expansion zbecker Thu, 02/29/2024 - 15:09
Endo agrees to $465M bankruptcy deal with federal government, inks 2 opioid settlements esagonowsky Thu, 02/29/2024 - 13:47
Fierce Pharma Asia—BeiGene's 1,400 new hires; BMS' India innovation hub; Evrenzo's China growth aliu Thu, 02/29/2024 - 13:46
With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US esagonowsky Thu, 02/29/2024 - 11:28
After setting out on its own, Sandoz inks $265M deal to resolve 'legacy' price-fixing lawsuit fkansteiner Thu, 02/29/2024 - 10:27
In atypical Big Pharma-VC pact, Gilead secures $210M from Abingworth to fund Trodelvy trials aliu Thu, 02/29/2024 - 09:58
GSK avoids trial with another Zantac settlement in California kdunleavy Thu, 02/29/2024 - 09:53
CoreRx strikes $130M deal to snap up struggling small-molecule specialist Societal CDMO fkansteiner Thu, 02/29/2024 - 09:20
Pfizer's Abrysvo maintains strong efficacy through 2nd RSV season, study finds kdunleavy Thu, 02/29/2024 - 07:27